24.15 USD
↘ 0.95 (3.78%)AT CLOSE (11:59 AM EDT)
Sutro Biopharma, Inc.
STRONASDAQ • USD
24.13
↘ 0.02 (0.10%)
POST MARKET (AS OF 07:48 PM EDT)
Post Market
AS OF 07:48 PM EDT
24.13
↘ 0.02 (0.10%)
Market: CLOSED
Sutro Biopharma, Inc. (STRO) trades at $24.02 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (229.6%) and a bullish Golden Cross on the moving averages. STRO is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 6, 2026.
Open?$24.96
High?$25.90
Low?$23.62
Prev. Close?$25.10
Volume?154.0K
Avg. Volume?394.5K
VWAP?$24.67
Rel. Volume?0.39x
Bid / Ask
Bid?$24.38 × 2.4K
Ask?$30.92 × 300
Spread?$6.54
Midpoint?$27.65
Valuation & Ratios
Market Cap?415.9M
Shares Out?16.6M
Float?15.0M
Float %?90.5%
P/E Ratio?N/A
P/B Ratio?-6.22
EPS?-$9.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Themes
Employees
133
Market Cap
415.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-09-27
Address
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-392-8412
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?85
Short Sent.?30
Piotroski F-Score?3/9Weak
Altman Z-Score?-5.55Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?11.02%High
Short Interest?1.7M
Days to Cover?4.5
Free Float15.0M
Avg Daily Volume370.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?3.12Strong
Quick Ratio?3.12Strong
Cash Ratio?1.04Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?-6.22CHEAP▾
S&P97
P/S?4.18FAIR▾
Peers100
S&P36
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
S&P97
EV/Sales?3.44FAIR▾
Peers100
S&P55
Returns & Efficiency
ROE?229.6%STRONG▾
Peers50
S&P97
ROA?-63.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-152139000
Enterprise Value?$342.2M
Fundamentals ratios updated end of day